These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8072943)

  • 21. Immunopathogenesis of vitiligo.
    Sandoval-Cruz M; García-Carrasco M; Sánchez-Porras R; Mendoza-Pinto C; Jiménez-Hernández M; Munguía-Realpozo P; Ruiz-Argüelles A
    Autoimmun Rev; 2011 Oct; 10(12):762-5. PubMed ID: 21334464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased total numbers of peripheral blood lymphocytes with elevated percentages of CD4+CD45RO+ and CD4+CD25+ of T-helper cells in non-segmental vitiligo.
    Mahmoud F; Abul H; Haines D; Al-Saleh C; Khajeji M; Whaley K
    J Dermatol; 2002 Feb; 29(2):68-73. PubMed ID: 11890298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ
    Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
    Lee AY; Kim NH; Choi WI; Youm YH
    J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An immunohistological study of cutaneous lymphocytes in vitiligo.
    Badri AM; Todd PM; Garioch JJ; Gudgeon JE; Stewart DG; Goudie RB
    J Pathol; 1993 Jun; 170(2):149-55. PubMed ID: 8345407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melanocyte-specific, cytotoxic T cell responses in vitiligo: the effective variant of melanoma immunity?
    Garbelli S; Mantovani S; Palermo B; Giachino C
    Pigment Cell Res; 2005 Aug; 18(4):234-42. PubMed ID: 16029417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma Inhibits Melanogenesis and Induces Apoptosis in Melanocytes: A Pivotal Role of CD8+ Cytotoxic T Lymphocytes in Vitiligo.
    Yang L; Wei Y; Sun Y; Shi W; Yang J; Zhu L; Li M
    Acta Derm Venereol; 2015 Jul; 95(6):664-70. PubMed ID: 25721262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Th17 cells and activated dendritic cells are increased in vitiligo lesions.
    Wang CQ; Cruz-Inigo AE; Fuentes-Duculan J; Moussai D; Gulati N; Sullivan-Whalen M; Gilleaudeau P; Cohen JA; Krueger JG
    PLoS One; 2011 Apr; 6(4):e18907. PubMed ID: 21541348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
    Yu HS; Kao CH; Yu CL
    J Invest Dermatol; 1993 Jun; 100(6):823-8. PubMed ID: 8496622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of antibodies to melanocytes in vitiligo by western immunoblotting.
    Hann SK; Shin HK; Park SH; Reynolds SR; Bystryn JC
    Yonsei Med J; 1996 Dec; 37(6):365-70. PubMed ID: 9048487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for an autoimmune pathogenesis of vitiligo.
    Ongenae K; Van Geel N; Naeyaert JM
    Pigment Cell Res; 2003 Apr; 16(2):90-100. PubMed ID: 12622785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
    van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
    Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth of human melanocytes from suction blister of localized vitiligo patient and from foreskins of newborns and adults by modified culture medium.
    Jee SH; Kuo YF; Wu YC; Chang CH; Kuo WL; Lü YC
    J Formos Med Assoc; 1993 Jan; 92(1):7-14. PubMed ID: 8099831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis.
    Raam L; Kaleviste E; Šunina M; Vaher H; Saare M; Prans E; Pihlap M; Abram K; Karelson M; Peterson P; Rebane A; Kisand K; Kingo K
    Front Immunol; 2018; 9():2707. PubMed ID: 30515176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
    Kim NH; Lee AY
    Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
    Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
    J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunodetection of the MCHR1 antibody in vitiligo patient sera.
    Zhou M; Guan C; Lin F; Xu W; Fu L; Hong W; Wan Y; Xu A
    Int J Mol Med; 2011 May; 27(5):725-9. PubMed ID: 21369690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical study of melanocyte-melanocyte stem cell lineage in vitiligo; a clue to interfollicular melanocyte stem cell reservoir.
    Seleit I; Bakry OA; Abdou AG; Dawoud NM
    Ultrastruct Pathol; 2014 May; 38(3):186-98. PubMed ID: 24460782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.